Surfactant class drugs

1 result
  • curosurf

    (poractant alfa)
    Chiesi USA, Inc.
    CUROSURF® (poractant alfa) is indicated for the rescue treatment of Respiratory Distress Syndrome (RDS) in premature infants, helping to reduce mortality and the occurrence of pneumothoraces associated with the condition.